Judgment of the Court (Third Chamber), 12 December 2013

Eli Lilly and Company Ltd v Human Genome Sciences Inc

Request for a preliminary ruling from the High Court of Justice (England and Wales), Chancery Division (Patents Court)

Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining such a certificate — Concept of a ‘product protected by a basic patent in force’ — Criteria — Wording of the claims of the basic patent — Precision and specificity — Functional definition of an active ingredient — Structural definition of an active ingredient — European Patent Convention

Case C‑493/12


Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex Autres Liens
Judgment (OJ)
31/01/2014 Eli Lilly and Company
Judgment
ECLI:EU:C:2013:835
12/12/2013 Eli Lilly and Company
Judgment (Summary)
ECLI:EU:C:2013:835
12/12/2013 Eli Lilly and Company
Application (OJ)
14/12/2012 Eli Lilly and Company
Top of the page Legal analysis of the decision or of the case

Reports of Cases

published in the electronic Reports of Cases (Court Reports - general)

Subject-matter

Reference for a preliminary ruling – High Court of Justice (Chancery Division) – Interpretation of Article 3(3) of the Council Directive 92/12/EEC of 25 February 1992 on the general arrangements for the holding, movement and monitoring of products subject to excise duty (OJ 1992 L 76, p. 1) and of the first paragraph of Article 1(3)(a) of Council Directive 2008/118/EC of 16 December 2008 concerning the general excise duty and repealing Directive 92/12/EEC (OJ 1992 L 9, p. 12) – Lubricating oils – Oils used other than as fuel or as a fuel – Submission to excise – Harmonised excise duty levied on the consumption of energy products

Systematic classification scheme

1.
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.03 Supplementary protection certificates
        4.11.14.03.02 Conditions for obtaining a certificate
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.03 Supplementary protection certificates
        4.11.14.03.00 General


Citations of case-law or legislation

References in grounds of judgment

Operative part

Opinion

Information not available


Dates

Date of the lodging of the application initiating proceedings

  • 05/11/2012

Date of the Opinion

Information not available

Date of the hearing

Information not available

Date of delivery

12/12/2013


References

Publication in the Official Journal

Application: OJ C 9 from 12.01.2013, p.33

Judgment: OJ C 45 from 15.02.2014, p.14

Name of the parties

Eli Lilly and Company

Notes on Academic Writings

  1. Roset, Sébastien: Autorisation de mise sur le marché des médicaments et certificats complémentaires de protection (CCP), Europe 2014 Février Com. nº 2 p.46-47 (FR)
  2. Kupecz, András: Vier belangrijke HvJ EU-arresten over aanvullende beschermingscertificaten, Intellectuele eigendom & Reclamerecht 2014 p.156-181 (NL)
  3. Brückner, Christopher ; Lelkes, Robert: Abstract functional combinations after Actavis: what future?, Journal of Intellectual Property Law and Practice 2016 p.212-214 (EN)
  4. König, Gregor ; von Renesse, Dorothea: Der "spezifische Bezug" ist besser als sein Ruf!, 80 Jahre Patentgerichtsbarkeit in Düsseldorf (Ed. Carl Heymanns Verlag, Köln) 2016 p.293-310 (DE)



Procedural Analysis Information

Source of the question referred for a preliminary ruling

High Court of Justice (England & Wales), Chancery Division (Patents Court) - United Kingdom

Subject-matter

  • Approximation of laws
  • Intellectual, industrial and commercial property
  • - Patents

Provisions of national law referred to

Information not available

Provisions of international law referred to

Convention sur la délivrance de brevets européens (05/10/1973), art. 69 Protocole interprétatif de l'article 69 de la Convention sur le brevet européen (05/10/1973), art. 1er

Procedure and result

  • Reference for a preliminary ruling

Formation of the Court

troisième chambre (Cour)

Judge-Rapporteur

Toader

Advocate General

Jääskinen

Language(s) of the Case

  • English

Language(s) of the Opinion

    Information not available